Principal Investigator
Wungki Park, MD, MS
GI medical oncologist and physician-scientist at Memorial Sloan Kettering, developing KRAS/RAS-directed and immune-based precision therapies for pancreatic and biliary tract cancers.
23 publications →Our Team
People
A working roster for the sPARK research community. Individual bios can be added later as profiles are confirmed.
Faculty
Eileen M. O'Reilly
Faculty
Fiyinfolu Balogun, MD, PhD
Faculty
Joshua Schoenfeld
Faculty
Michael May
Senior Research Scholar
Marc Hilmi
Research Scholar
Vincenzo Nasca
Leads the lab’s translational work in biliary tract cancer (BTC), extending KRAS/RAS-directed strategies into BTC as part of the GRIT initiative.
Clinical Fellow
Junmin Song, MD
Visiting Scientist
Daeseong Kim, MD
First author of the lab’s inaugural biliary tract cancer study, identifying PI3K-pathway activation as a molecular determinant of chemotherapy benefit in advanced BTC (Clinical and Molecular Hepatology, 2026).
1 publication →Medical Student
Catherine O'Connor
Student